Put Options

9 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$0.53 - $1.34 $63,441 - $160,398
-119,700 Reduced 90.54%
12,500 $7,000
Q2 2024

Aug 15, 2024

BUY
$1.14 - $2.97 $7,409 - $19,305
6,500 Added 5.17%
132,200 $169,000
Q1 2024

May 07, 2024

SELL
$1.95 - $4.04 $126,750 - $262,600
-65,000 Reduced 34.08%
125,700 $354,000
Q4 2023

Feb 14, 2024

BUY
$2.32 - $5.51 $185,600 - $440,800
80,000 Added 72.27%
190,700 $562,000
Q3 2023

Nov 14, 2023

SELL
$2.49 - $11.85 $427,533 - $2.03 Million
-171,700 Reduced 60.8%
110,700 $280,000
Q2 2023

Aug 11, 2023

BUY
$6.39 - $28.58 $1.6 Million - $7.16 Million
250,400 Added 782.5%
282,400 $1.88 Million
Q1 2023

May 16, 2023

SELL
$17.7 - $33.24 $56,640 - $106,368
-3,200 Reduced 9.09%
32,000 $597,000
Q4 2022

Feb 14, 2023

SELL
$10.25 - $22.43 $145,550 - $318,506
-14,200 Reduced 28.74%
35,200 $756,000
Q3 2022

Nov 14, 2022

SELL
$11.19 - $17.89 $325,629 - $520,599
-29,100 Reduced 37.07%
49,400 $584,000

Others Institutions Holding BTAI

About BioXcel Therapeutics, Inc.


  • Ticker BTAI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 28,022,500
  • Market Cap $9.53M
  • Description
  • BioXcel Therapeutics, Inc. is a commercial-stage biopharmaceutical company utilizing artificial intelligence approaches to develop transformative medicines in neuroscience and immuno-oncology. The company's drug re-innovation approach leverages existing approved drugs and/or clinically validated product candidates together with big data and prop...
More about BTAI
Track This Portfolio

Track Susquehanna International Group, LLP Portfolio

Follow Susquehanna International Group, LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.